Therapeutic Potential of Mineralocorticoid Receptors in Skeletal Muscle Aging

Skeletal muscle aging, or sarcopenia, involves progressive muscle mass and function loss, which limits mobility and independence in elderly populations. This decline is driven by chronic inflammation, oxidative stress, and insulin resistance, all of which impair muscle regeneration and accelerate pr...

Full description

Bibliographic Details
Published in:	Receptors
Main Authors:	Ricardo Aparecido Baptista Nucci, Otávio de Toledo Nóbrega, Wilson Jacob-Filho
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Subjects:	elderly mineralocorticoid sarcopenia
Online Access:	https://www.mdpi.com/2813-2564/4/3/13

Similar Items

Expression of genes encoding mineralocorticoid biosynthetic enzymes and the mineralocorticoid receptor, and levels of mineralocorticoids in the bovine follicle and corpus luteum
by: Memory MUKANGWA, et al.
Published: (2019-12-01)

Mineralocorticoid receptor overactivation-induced remodeling of obese adipose tissue
by: WEN Runzhi, WANG Li, ZHAO Naiqian
Published: (2025-06-01)

Obesity, aldosterone excess, and mineralocorticoid receptor activation: Parallel or intersected circumstances?
by: Houry Puzantian, et al.
Published: (2024-12-01)

The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice
by: Stefanny M. Figueroa, et al.
Published: (2023-04-01)

Mineralocorticoid Receptor Signaling in the Inflammatory Skeletal Muscle Microenvironments of Muscular Dystrophy and Acute Injury
by: Zachary M. Howard, et al.
Published: (2022-06-01)

Mineralocorticoid receptor antagonists reduce inflammatory signaling independent of myofiber mineralocorticoid receptor
by: Jeovanna Lowe, et al.
Published: (2025-12-01)

In Silico Investigation of Mineralocorticoid Receptor Antagonists: Insights into Binding Mechanisms and Structural Dynamics
by: Julia J. Liang, et al.
Published: (2025-03-01)

Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging
by: Stefania Gorini, et al.
Published: (2019-08-01)

Mineralocorticoid Receptor Blocker Prevents Mineralocorticoid Receptor–Mediated Inflammation by Modulating Transcriptional Activity of Mineralocorticoid Receptor–p65–Signal Transducer and Activator of Transcription 3 Complex
by: Naoto Kuyama, et al.
Published: (2024-09-01)

Research progress on the effects of mineralocorticoid receptor on cardiovascular diseases
by: MA Qian-yu, PENG Shi, ZHANG Zhao-yuan, ZHANG Dan, ZHANG Jin
Published: (2022-08-01)

Role of glucocorticoid and mineralocorticoid receptors in rainbow trout (Oncorhynchus mykiss) skeletal muscle: A transcriptomic perspective of cortisol action
by: Jorge E. Aedo, et al.
Published: (2023-01-01)

Heart failure: the role for mineralocorticoid receptor antagonists
by: Bertram Pitt
Published: (2014-05-01)

Cell-type specific effects of mineralocorticoid receptor gene expression suggest intercellular communication regulating fibrosis in skeletal muscle disease
by: Chetan K. Gomatam, et al.
Published: (2024-04-01)

The role of mineralocorticoid receptors hyperactivation in the development of cardiorenal complications in patients with diabetes mellitus, perspective of the selective nonsteroidal mineralocorticoid receptors antagonist’s treatment: A review
by: Irina N. Bobkova
Published: (2023-11-01)

Eplerenone, a mineralocorticoid receptor inhibitor, reduces cirrhosis associated changes of hepatocyte glucose and lipid metabolism
by: Mohammad Mohabbulla Mohib, et al.
Published: (2024-12-01)

Paradigm shift on the role of mineralocorticoid receptor antagonists in hypertension therapy
by: S. R. Gilyarevsky, et al.
Published: (2023-10-01)

case of liquorice-infused marijuana causing syndrome of apparent mineralocorticoid excess
by: Asnia Latif, et al.
Published: (2023-08-01)

Blockade of mineralocorticoid receptor by low-dose spironolactone rescues hypothalamic-ovarian dysfunction in PCOS experimental rat model
by: Stephanie E. Areleogbe, et al.
Published: (2022-12-01)

Vascular cell‐specific roles of mineralocorticoid receptors in pulmonary hypertension
by: Divya P. Menon, et al.
Published: (2021-07-01)

Investigating the efficacy of mineralocorticoid receptor antagonists for cardiovascular outcomes in different diseases
by: Jiao Wang, et al.
Published: (2025-08-01)

Overexpression of mineralocorticoid receptors does not affect memory and anxiety-like behavior in female mice
by: Sofia eKanatsou, et al.
Published: (2015-07-01)

The Role of Aldosterone and the Mineralocorticoid Receptor in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Mohammed Barigou, et al.
Published: (2025-07-01)

Mineralocorticoid Receptor Antagonists Eplerenone and Spironolactone Modify Adrenal Cortex Morphology and Physiology
by: Sofia S. Pereira, et al.
Published: (2021-04-01)

MINERALOCORTICOID RECEPTOR ANTAGONISTS THERAPY IN RESISTANT HYPERTENSION: TIME TO IMPLEMENT NEW GUIDELINES?
by: Giuseppe eMaiolino, et al.
Published: (2015-02-01)

New Perspectives on Sex Steroid and Mineralocorticoid Receptor Signaling in Cardiac Ischemic Injury
by: Laura A. Bienvenu, et al.
Published: (2022-06-01)

The Cardiac Mineralocorticoid Receptor (MR): A Therapeutic Target Against Ventricular Arrhythmias
by: Michel F. Rossier, et al.
Published: (2021-06-01)

Cardiac response to chronic restraint stress involves mineralocorticoid receptors in male Sprague–Dawley rats
by: D. Sztechman, et al.
Published: (2025-10-01)

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
by: Nina Vodošek Hojs, et al.
Published: (2021-06-01)

Cardiovascular-Kidney-Metabolic Effects: Steroidal and Nonsteroidal Mineralocorticoid Receptor Antagonists
by: Biykem Bozkurt, et al.
Published: (2025-07-01)

Effects of Mineralocorticoid Receptors Blockade on FearMemory Reconsolidation in Rats
by: Abbas Ali Vafaei, et al.
Published: (2011-08-01)

Effects of Mineralocorticoid Receptors Blockade on FearMemory Reconsolidation in Rats
by: Ali Rashidy-Pour, et al.
Published: (2011-08-01)

Mineralocorticoid receptor blockade with finerenone improves heart function and exercise capacity in ovariectomized mice
by: Marie Pieronne‐Deperrois, et al.
Published: (2021-06-01)

Mineralocorticoid receptor antagonist use after hospitalization of patients with heart failure and post-discharge outcomes: a single-center retrospective cohort study
by: Matthew S. Durstenfeld, et al.
Published: (2019-08-01)

A comprehensive review of finerenone—a third-generation non-steroidal mineralocorticoid receptor antagonist
by: Shuhui Zhai, et al.
Published: (2024-09-01)

Chemokine receptor CXCR7 antagonism ameliorates cardiac and renal fibrosis induced by mineralocorticoid excess
by: Bing H. Wang, et al.
Published: (2024-11-01)

Combinatorial actions of glucocorticoid and mineralocorticoid stress hormone receptors are required for preventing neurodegeneration of the mouse hippocampus
by: Robert H. Oakley, et al.
Published: (2021-11-01)

Mineralocorticoid receptor antagonists in the treatment of patients with heart failure after myocardial infarction and those with chronic heart failure
by: S N Tereshchenko, et al.
Published: (2013-12-01)

Steroidal Mineralocorticoid Receptor Antagonist Side Effects and Reasons for Discontinuation: A Patient Survey (RELICS-PS)
by: Richard EL, et al.
Published: (2025-04-01)

Prognostic impact of additional mineralocorticoid receptor antagonists in octogenarian heart failure patients
by: Takuro Abe, et al.
Published: (2020-10-01)

Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection
by: A. M. Esayan, et al.
Published: (2018-04-01)